Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí hóa học đề tài : Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device) | BioMed Central Health and Quality of Life Outcomes Research Understanding and assessing the impact of treatment in diabetes the Treatment-Related Impact Measures for Diabetes and Devices TRIM-Diabetes and TRIM-Diabetes Device Meryl Brod f1 Mette Hammed2 Torsten Christensen 2 Suzanne Lessardf1 and Donald M Bushnelh3 Address Hhe Brod Group 219 Julia Avenue Mill Valley California 94941 USA 2Novo Nordisk A S Global Development Krogshojvej 29 2880 Bagsv rd Denmark and 3Health Research Associates 6505 216th Street SW Suite 105 Mountlake Terrace Washington 98043 USA Email Meryl Brod - mbrod@ Mette Hammer - mthm@ Torsten Christensen - tluc@ Suzanne Lessard - suzanne@ Donald M Bushnell - bushnell@ Corresponding author fEqual contributors Open Access Published 9 September 2009 Received 6 May 2009 Health and Quality of Life Outcomes 2009 7 83 doi 1477-7525-7-83 Accepted 9 September 2009 This article is available from http content 7 1 83 2009 Brod et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Purpose Diabetes is a debilitating illness requiring lifelong management. Treatments can be varied in terms of mode of administration as well as type of agent. Unfortunately most patient reported outcome measures currently available to assess the impact of treatment are specific to diabetes type treatment modality or delivery systems and are designed to be either a HRQoL or treatment satisfaction measure. To address these gaps the Treatment Related Impact Measure-Diabetes and Device measures were developed. This paper presents the item development and validation of the TRIM Diabetes Device. Methods Patient interviews were conducted to .
